Kenya AIDS Vaccine Initiative
About Kenya AIDS Vaccine Initiative
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
International AIDS Vaccine Initiative
3
Clinical Trials at Kenya AIDS Vaccine Initiative
During the past decade, Kenya AIDS Vaccine Initiative conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines
2011-02-01
2012-11-01
Completed
147
Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
2013-03-01
Completed
65
A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults
2018-12-03
2023-08-30
Active, not recruiting
61
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kenya AIDS Vaccine Initiative"
#1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Fred Hutchinson Cancer Research Center - Seattle HIV Vaccine Trials Unit" with 1 trials as a collaborator, "Kenya AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR)" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Kenya AIDS Vaccine Initiative
According to Clinical.Site data, the most researched conditions in "Kenya AIDS Vaccine Initiative" are
"HIV Infections" (3 trials). Many other conditions were trialed in "Kenya AIDS Vaccine Initiative" in a lesser frequency.
Clinical Trials Intervention Types at Kenya AIDS Vaccine Initiative
Most popular intervention types in "Kenya AIDS Vaccine Initiative" are "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Ad35 investigational HIV vaccine" (1 trials), "Ad35-GRIN (0.5mL)" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 1" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 2" (1 trials) and "BG505 SOSIP.664 gp140, adjuvanted" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kenya AIDS Vaccine Initiative
The vast majority of trials in "Kenya AIDS Vaccine Initiative" are
3 trials for "All" genders.
Clinical Trials Status at Kenya AIDS Vaccine Initiative
Currently, there are NaN active trials in "Kenya AIDS Vaccine Initiative".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kenya AIDS Vaccine Initiative,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kenya AIDS Vaccine Initiative, 3 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".